We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The National Health Commission of China issued the Administrative Measures for the Clinical Use of Oncology Drugs (Draft for Comment) on July 29 in order to strengthen the administration of the clinical use of medical institutions’ oncology drugs.